Abstract − Analytical Sciences, 17(3), 467 (2001).
Crystal Structure of an Antidiabetic Agent, (±)-5-[4-(6-Hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazollidine, Troglitazone Dihydrate
Katsuhiro KOBAYASHI,* Hiroshi FUKUHARA,* and Tadashi HATA**
*Process Development Laboratories, Sankyo Co. Ltd., 173 Nakahara-Kamijuku, Hiratsuka, Kanagawa 254-8560, Japan
**Biomedical Research Laboratories, Sankyo Co. Ltd., 1-2-58 Hiromachi, Shinagawa, Tokyo 140-8710, Japan
**Biomedical Research Laboratories, Sankyo Co. Ltd., 1-2-58 Hiromachi, Shinagawa, Tokyo 140-8710, Japan
J-STAGE:
View this article in J-STAGE
Back to the Table of Contents
